These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 5366785)
1. [Concentration of tubazid, PAS and streptomycin in the blood and lung tissue in standard and intravenous administration]. Kovalenko NN Vrach Delo; 1969 Oct; 10():134-5. PubMed ID: 5366785 [No Abstract] [Full Text] [Related]
2. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis]. Pilipchuk NS; Ivaniuota OM; Kovalenko NN Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441 [No Abstract] [Full Text] [Related]
3. [The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS]. Golanov VS Vrach Delo; 1969 Jun; 6():62-6. PubMed ID: 5821665 [No Abstract] [Full Text] [Related]
4. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP]. Sabula MM Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779 [No Abstract] [Full Text] [Related]
5. [Bacteriostatic concentration of tubazid, streptomycin and PAS in the blood of tuberculous patients in separate and combined administration of the drugs]. Bibik NF Probl Tuberk; 1969; 47(4):58-62. PubMed ID: 5368447 [No Abstract] [Full Text] [Related]
6. [Excretion and concentration of tubazid, PAS and their metabolites in patients with tuberculosis and different functional conditions of kidneys]. Savula MM Sov Med; 1973 Sep; 36(9):146-7. PubMed ID: 4756491 [No Abstract] [Full Text] [Related]
7. [Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis]. Brant AL; Semenova EA Antibiotiki; 1981 Aug; 26(8):628-32. PubMed ID: 7294755 [TBL] [Abstract][Full Text] [Related]
8. [On the fate of tuberculostatics in macro- and microorganisms]. Iwainsky H; Reutgen H; Sehrt I; Grunert M Z Tuberk Erkr Thoraxorg; 1967 Apr; 126(1):106-30. PubMed ID: 4876797 [No Abstract] [Full Text] [Related]
9. Stability of antituberculosis drugs in Löwenstein-Jensen medium. Clark J J Med Lab Technol; 1967 Jul; 24(3):212-3. PubMed ID: 4292493 [No Abstract] [Full Text] [Related]
10. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis]. Tytor IaM Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592 [No Abstract] [Full Text] [Related]
11. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS). Hanngren A; Borgå O; Sjöqvist F Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864 [No Abstract] [Full Text] [Related]
12. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)]. Burghard G; Petitjean R; Schranz J; Scherrer B Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514 [No Abstract] [Full Text] [Related]
13. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)]. Charpin J; Taranger J; Boutin C; Girbal JP Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168 [No Abstract] [Full Text] [Related]
14. [Interaction of streptomycin, Tubazid and PAS according to myorelaxant and lethal effects]. Soloviev NV; Berezhinskaia VV Antibiotiki; 1973 Mar; 18(3):249-52. PubMed ID: 4764220 [No Abstract] [Full Text] [Related]
15. Absorption of sulphonamides and antitubercular drugs from the rat lung. Burton JA; Schanker LS Xenobiotica; 1974 May; 4(5):291-6. PubMed ID: 4407063 [No Abstract] [Full Text] [Related]
16. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)]. Ortenberg ZA Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263 [No Abstract] [Full Text] [Related]
17. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol. Lehmann J Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904 [No Abstract] [Full Text] [Related]
18. Modification by para-aminosalicylic acid and sulfamethazine of the isoniazid inactivation in man. Tiitinen H Scand J Respir Dis; 1969; 50(4):281-90. PubMed ID: 5380785 [No Abstract] [Full Text] [Related]
19. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug]. Mariani B; Bisetti A; Monzali G G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966 [No Abstract] [Full Text] [Related]
20. [Treatment of siderosilicotuberculosis patients with intravenous administration of antibacterial preparations]. Malov VV; Buidenok TV Probl Tuberk; 1972; 50(6):66-7. PubMed ID: 5051131 [No Abstract] [Full Text] [Related] [Next] [New Search]